NCT01013064View on ClinicalTrials.gov

A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
Healthy
Interventions
DRUG

HM10760A or Placebo

0.04 mcg/kg to 2.0mcg/kg once intravenously

Trial Locations (1)

Unknown

Hanmi Clinical, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01013064 - A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects | Biotech Hunter | Biotech Hunter